New
Adapter Tracks Airway Pressure Visually, Ensuring Therapeutic
Effectiveness of Respiratory Treatment.
Plattsburgh,
NY, USA (January 21, 2016) -- Monaghan Medical Corporation (MMC)
(http://www.monaghanmed.com),
a leader in the development, manufacture, and marketing of
respiratory devices, today announced the release of a new Manometer
Adapter for its Aerobika® Oscillating Positive Expiratory
Pressure (OPEP) device-a drug-free, clinically supported device that
reduces coughing and breathlessness, increases lung hygiene, and
improves gas transfer. The Manometer Adapter serves as a visual
compliance tool for the Aerobika® OPEP to assist respiratory
therapists and patients in assessing respiratory therapy that calls
for active exhalation.
The
MMC Aerobika® OPEP device improves respiration by clearing
mucus from the lungs through exhalation. OPEP therapy is highly
effective in postoperative patients for airway clearance and lung
hygiene, and for patients with chronic respiratory conditions such as
cystic fibrosis. With the addition of a Manometer Adapter,
respiratory therapists, clinicians, and patients can literally see
with their own eyes how well the patient is using the device.
The
Aerobika® OPEP device works by using active exhalation: The
patient wraps his or her mouth around the OPEP mouthpiece and
exhales, while the device uses pulses of air resistance to release
mucus trapped in smaller air pathways. The Manometer Adapter allows
clinicians to measure the pressure exerted by active exhalation to
determine therapeutic effectiveness. It is ideal for clinical
training, ensuring that the OPEP device is used properly.
The
Manometer Adapter-which has an easy-to-read scale that shows green
when active exhalation is in the target zone of 5 cm to 20 cm
H2O-provides immediate patient feedback and confirms that the patient
is achieving therapeutic pressure every time the OPEP device is used.
"Postoperative
patients and patients with severe respiratory conditions needed a new
kind of respiratory treatment," says Dom Coppolo, Vice President
of Clinical Strategy and Development at Monaghan Medical Corporation.
"That's why we developed the Aerobika® OPEP Therapy
System-to help treat ailments with a productive cough seeking a
non-therapeutic method of removing mucus from the lungs. With the
addition of the Manometer Adapter, we now have an OPEP device that is
easy to use and easy to monitor. The Manometer Adapter provides a
baseline for active exhalation therapy so practitioners can measure
patients' recovery progress.
"We
are committed to providing products that ensure patients continue
treatment and control their symptoms," Coppolo says. "Providing
metrics to measure treatment efficacy only speeds recovery."
The
Aerobika® OPEP is suitable for various patient treatments,
such as post-operative thoracic recovery, lung volume expansion
therapy, and atelectasis treatment, reducing the risk of pulmonary
complications. The Aerobika® OPEP is easy to use, has no side
effects or interactions since it is drug-free, and, with the new
Manometer Adapter, makes it easier than ever to monitor therapeutic
pressure levels.
For
more information, visit http://www.Aerobikaopep.com.
About
Monaghan Medical
Monaghan
Medical Corporation (MMC), headquartered in Plattsburgh, New York
(USA), is a leader in the development, manufacture, and marketing of
respiratory devices, from the flagship AeroChamber® Brand of
Valved Holding Chamber (VHC) for asthma patients to the latest
state-of-the-art Aerobika® OPEP therapy. MMC's products are
developed and validated by its sister company's world-renowned
Trudell Medical Aerosol Institute and are supported by more than 500
peer reviewed and published articles.
Contact:
Dominic
P. Coppolo
Vice
President of Clinical Strategy and Development
Monaghan
Medical Corporation
800-343-9071
